// App-Quantinova.ai

1502 : Dasatinib Drug Use Results Surveys For All Cases As Nationwide Real World Data

Researchers

Presenter

  • Yasuhito Nannya

Principal Investigators

  • Kiyohiko Hatake

  • Mineo Kurokawa

  • Mihoko Nishizawa

  • Jumpei Tetsuka

  • Machida Meiji

  • Tamada Hiroshi

Medical Centers

  • Department of Gastroenterology, Graduate School of Medicine Kobe University, Kobe, Japan

  • Bristol-Myers K.K, Tokyo, Japan

  • Department of Hematology and Oncology, Cancer Institute Hospital, Japanese Foundation For Cancer Research, Tokyo, Japan

  • Bristol-Myers K.K, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Acute lymphoblastic leukemia

  • Chronic Myelogenous Leukemia

  • Thrombocytopenia

  • Neutropenia

  • Depression

  • Anemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • dasatinib

  • Imatinib

  • IkT001

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved